| HepG2 | 
Caption: IP-Western Blot analysis of HepG2 whole cell lysate using EIF3H specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-EIF3H antibody (lanes under 'EIF3H'). Method: immunoprecipitation Releated Sample: eCLIP:545 Status: Released Lab: Yeo Lab | 
Caption: Western blot following CRISPR against EIF3H in HepG2 whole cell lysate using EIF3H specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EIF3H. EIF3H protein appears as the green band, Tubulin serves as a control and appears in red. Releated Sample: BGHcLV05-15 Status: Released Lab: Graveley Lab |
|---|
| K562 | 
Caption: IP-Western Blot analysis of K562 whole cell lysate using EIF3H specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-EIF3H antibody (lanes under 'EIF3H'). Method: immunoprecipitation Status: Released Lab: Yeo Lab | 
Caption: Western blot following CRISPR against EIF3H in K562 whole cell lysate using EIF3H specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EIF3H. EIF3H protein appears as the green arrow, Tubulin serves as a control and appears in red arrow. Releated Sample: BGKcLV04-11 Status: Released Lab: Graveley Lab |
|---|